EADV 2024 Insights


 

EADV 2024 Insights: Change In Patient-Reported Hair Satisfaction During Deuruxolitinib Treatment of Severe Alopecia Areata: Pooled Data From The Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials

75 views
October 17, 2024
Comments 0
Login to view comments. Click here to Login